MX344141B - Preparacion solida recubierta. - Google Patents
Preparacion solida recubierta.Info
- Publication number
- MX344141B MX344141B MX2012007997A MX2012007997A MX344141B MX 344141 B MX344141 B MX 344141B MX 2012007997 A MX2012007997 A MX 2012007997A MX 2012007997 A MX2012007997 A MX 2012007997A MX 344141 B MX344141 B MX 344141B
- Authority
- MX
- Mexico
- Prior art keywords
- solid preparation
- montelukast
- coated solid
- coated
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Un objetivo de la presente invención es proporcionar una preparación sólida recubierta que contiene montelukast, que se puede aplicar a un empaque de una dosis, en donde la estabilidad a la humedad de montelukast o una sal farmacológicamente aceptable del mismo contenida en el mismo se mantiene incluso cuando la preparación se desempaca. La presente invención proporciona una preparación sólida recubierta que contiene como un ingrediente activo montelukast o una sal farmacológicamente aceptable del mismo y que está recubierta con una capa de recubrimiento que comprende alcohol polivinílico y arcilla de expansión, en donde la relación en masa del alcohol polivinílico descrito en lo anterior respecto a la arcilla de expansión descrito en lo anterior en la capa de recubrimiento descrita en lo anterior es de 8:2 a 3:7.+.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010042066 | 2010-02-26 | ||
| PCT/JP2011/054256 WO2011105539A1 (ja) | 2010-02-26 | 2011-02-25 | 被覆固形製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2012007997A MX2012007997A (es) | 2012-08-23 |
| MX344141B true MX344141B (es) | 2016-12-07 |
Family
ID=44506936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012007997A MX344141B (es) | 2010-02-26 | 2011-02-25 | Preparacion solida recubierta. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8658208B2 (es) |
| EP (1) | EP2540298B1 (es) |
| JP (1) | JP5761018B2 (es) |
| KR (1) | KR101445671B1 (es) |
| CN (1) | CN102762205B (es) |
| BR (1) | BR112012015923A2 (es) |
| CA (1) | CA2785694C (es) |
| ES (1) | ES2552628T3 (es) |
| HU (1) | HUE026633T2 (es) |
| MX (1) | MX344141B (es) |
| PL (1) | PL2540298T3 (es) |
| SI (1) | SI2540298T1 (es) |
| TW (1) | TWI480067B (es) |
| WO (1) | WO2011105539A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI438012B (zh) | 2008-12-25 | 2014-05-21 | Toray Industries | 固態製劑用之塗覆劑及使用其之固態製劑 |
| GB2509460A (en) * | 2011-09-29 | 2014-07-02 | Meditop Gy Gyszeripari Kft | Coating Composition |
| KR101278572B1 (ko) * | 2011-10-18 | 2013-06-25 | 주식회사 네비팜 | 류코트리엔 길항제와 에피나스틴의 복합제제 |
| CN102973532A (zh) * | 2012-12-28 | 2013-03-20 | 南京瑞尔医药有限公司 | 一种稳定的孟鲁司特钠片剂及制备方法 |
| TWI658842B (zh) * | 2014-03-31 | 2019-05-11 | 日商東麗股份有限公司 | 固體製劑用之被覆劑以及由其所形成之被膜及被覆固體製劑 |
| JP7194524B2 (ja) * | 2018-06-25 | 2022-12-22 | 日本酢ビ・ポバール株式会社 | コーティング組成物並びに経口固形剤及びその製造方法 |
| EP3846792A4 (en) | 2018-09-06 | 2022-10-12 | Innopharmascreen Inc. | METHODS AND COMPOSITIONS FOR TREATING ASTHMA OR PARKINSON'S DISEASE |
| US20210113715A1 (en) * | 2018-09-14 | 2021-04-22 | Cedars-Sinai Medical Center | Targeted nanoparticles for diagnosing, detecting and treating cancer |
| WO2023224097A1 (ja) * | 2022-05-18 | 2023-11-23 | 東和薬品株式会社 | 膜形成用組成物、膜状組成物及びその利用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5157815A (en) * | 1974-11-14 | 1976-05-20 | Sumitomo Chemical Co | Toijono seizohoho |
| JPS5942325A (ja) * | 1982-09-03 | 1984-03-08 | Dai Ichi Seiyaku Co Ltd | コ−テイング用組成物及びコ−テイング製剤 |
| JPS61186313A (ja) | 1985-02-12 | 1986-08-20 | Dainippon Pharmaceut Co Ltd | バルプロ酸ナトリウム製剤 |
| JP2803179B2 (ja) * | 1989-06-28 | 1998-09-24 | 東洋紡績株式会社 | 被覆プラスチックフイルム |
| JPH03120211A (ja) | 1989-10-04 | 1991-05-22 | Earth Chem Corp Ltd | 粒状カルニチン製剤 |
| AU662429B2 (en) * | 1992-07-29 | 1995-08-31 | Sumitomo Chemical Company, Limited | Gas barrier resin composition and its film and process for producing the same |
| DE670160T1 (de) | 1994-03-01 | 1996-03-14 | Gerhard Gergely | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung. |
| CN1097619C (zh) * | 1994-07-12 | 2003-01-01 | 伯温德药品服务公司 | 隔潮膜涂层组合物及其生产方法以及涂层制品 |
| US5773031A (en) | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
| KR100510356B1 (ko) | 2001-02-27 | 2005-08-24 | 룀 게엠베하 운트 콤파니 카게 | 저장 안정성이 개선된 피복제 및 결합제를 포함하는 약제학적 제형 및 이의 제조방법 |
| NL1018607C2 (nl) * | 2001-07-20 | 2003-01-21 | Friesland Brands Bv | Vochtbarrière in voedingsmiddelen. |
| PT1678139E (pt) | 2003-10-10 | 2011-11-28 | Synhton B V | Montelucaste em estado sólido |
| WO2005074893A1 (en) | 2004-02-03 | 2005-08-18 | Chemagis Ltd. | Stable amorphous forms of montelukast sodium |
| JP2007145717A (ja) | 2005-11-24 | 2007-06-14 | Eisai R & D Management Co Ltd | フィルムコーティング製剤 |
| ES2277563B1 (es) * | 2005-12-29 | 2008-06-16 | Nanobiomatters, S.L. | Procedimiento de fabricacion de materiales nanocompuestos para aplicaciones multisectoriales. |
| EP1803457A1 (en) * | 2005-12-30 | 2007-07-04 | Krka Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical composition containing montelukast |
| JP2009526047A (ja) * | 2006-02-09 | 2009-07-16 | テバ ファーマシューティカル インダストリーズ リミティド | モンテルカストナトリウムの安定な医薬製剤 |
| GB0709541D0 (en) * | 2007-05-17 | 2007-06-27 | Jagotec Ag | Pharmaceutical excipient |
| US20090124657A1 (en) * | 2007-08-14 | 2009-05-14 | Ramesh Kappala | Pharmaceutical compositions comprising montelukast |
| TWI438012B (zh) * | 2008-12-25 | 2014-05-21 | Toray Industries | 固態製劑用之塗覆劑及使用其之固態製劑 |
| US8652521B2 (en) | 2009-03-27 | 2014-02-18 | Toray Industries, Inc. | Coated solid preparation |
-
2011
- 2011-02-25 KR KR1020127018048A patent/KR101445671B1/ko not_active IP Right Cessation
- 2011-02-25 BR BR112012015923-2A patent/BR112012015923A2/pt active Search and Examination
- 2011-02-25 MX MX2012007997A patent/MX344141B/es active IP Right Grant
- 2011-02-25 US US13/581,010 patent/US8658208B2/en not_active Expired - Fee Related
- 2011-02-25 CN CN201180011164.9A patent/CN102762205B/zh not_active Expired - Fee Related
- 2011-02-25 ES ES11747495.7T patent/ES2552628T3/es active Active
- 2011-02-25 EP EP11747495.7A patent/EP2540298B1/en not_active Not-in-force
- 2011-02-25 TW TW100106314A patent/TWI480067B/zh not_active IP Right Cessation
- 2011-02-25 WO PCT/JP2011/054256 patent/WO2011105539A1/ja active Application Filing
- 2011-02-25 HU HUE11747495A patent/HUE026633T2/en unknown
- 2011-02-25 CA CA2785694A patent/CA2785694C/en not_active Expired - Fee Related
- 2011-02-25 PL PL11747495T patent/PL2540298T3/pl unknown
- 2011-02-25 JP JP2011509337A patent/JP5761018B2/ja not_active Expired - Fee Related
- 2011-02-25 SI SI201130706T patent/SI2540298T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2540298T1 (sl) | 2016-02-29 |
| BR112012015923A2 (pt) | 2020-09-08 |
| TW201136618A (en) | 2011-11-01 |
| WO2011105539A1 (ja) | 2011-09-01 |
| ES2552628T3 (es) | 2015-12-01 |
| TWI480067B (zh) | 2015-04-11 |
| EP2540298A4 (en) | 2014-04-09 |
| US8658208B2 (en) | 2014-02-25 |
| CA2785694A1 (en) | 2011-09-01 |
| HUE026633T2 (en) | 2016-06-28 |
| CN102762205A (zh) | 2012-10-31 |
| MX2012007997A (es) | 2012-08-23 |
| KR20120098877A (ko) | 2012-09-05 |
| CN102762205B (zh) | 2014-03-12 |
| JPWO2011105539A1 (ja) | 2013-06-20 |
| CA2785694C (en) | 2013-12-17 |
| US20120321677A1 (en) | 2012-12-20 |
| EP2540298A1 (en) | 2013-01-02 |
| EP2540298B1 (en) | 2015-11-04 |
| KR101445671B1 (ko) | 2014-09-29 |
| JP5761018B2 (ja) | 2015-08-12 |
| PL2540298T3 (pl) | 2016-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012007997A (es) | Preparacion solida recubierta. | |
| AU2012259422A8 (en) | Solid forms of a pharmaceutically active substance | |
| EA201291028A1 (ru) | Полипропиленовая композиция, подходящая для нанесения покрытий экструзией | |
| WO2012017415A3 (en) | Dry composition wound dressings and adhesives | |
| JP2013510216A5 (es) | ||
| BR112012024139A2 (pt) | formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide. | |
| HUE037742T2 (hu) | Szubsztituált azolok, vírusellenes aktív adalék, gyógyszerészeti készítmény, az elõállításukat célzó eljárás és alkalmazásuk | |
| WO2009147075A3 (en) | Pharmaceutical compositions containing a crystalline form of posaconazole | |
| WO2013130898A3 (en) | Stabilizing agents and methods of use thereof | |
| TN2012000371A1 (en) | Pyrazole compounds as crth2 antagonists | |
| WO2012048176A3 (en) | Attachment and retention formulations for biologically active organic compounds | |
| PT2658844T (pt) | Novos derivados de pirimidinas, sua preparação e utilização farmacêutica como inibidores de fosforilação de akt (pkb) | |
| UA109281C2 (uk) | Фармацевтична композиція, яка містить похідне аміду або його фармацевтично прийнятну сіль | |
| EP2266626A4 (en) | COMPOSITION FOR TOPICAL APPLICATION WITH A TRANSCRIPTION FACTOR DECOY AS AN ACTIVE SUBSTANCE | |
| WO2012001705A3 (en) | Pharmaceutical compositions of (r)-lansoprazole | |
| EP2630956B8 (en) | Sustained-release pellets containing tacrolimus as an active ingredient | |
| MX344324B (es) | Endoprotesis que contiene un recubrimiento de substancia activa. | |
| WO2011140446A3 (en) | Pharmaceutical formulations | |
| WO2009060952A1 (ja) | 新規製剤 | |
| WO2014149176A3 (en) | Use of chromobacterium substugae formulations, compositions and compounds to modulate cornworm rootworm larvae infestation | |
| WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions | |
| CA2750209A1 (en) | Coated solid preparations of valproic acid | |
| WO2012074830A3 (en) | Modified release tranexamic acid formulation | |
| WO2014181195A3 (en) | Antiemetic extended release solid dosage forms | |
| EP2871187A4 (en) | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |